Company news

Sysmex Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Notice Regarding Completion of Cancellation of Treasury Stock

September 30, 2026

Announcement Regarding Revision of Financial Forecast for FY26 1H and FY26 full year

August 7, 2026

Notice Regarding the Status and Completion of Acquisition of Treasury Stock and Cancellation of Treasury Stock

July 21, 2026

High diagnostic performance of the random-access hiscl ptau-217, Aβ42 and Aβ40 plasma assays in detecting amyloid pathology across clinical stages

July 16, 2026

Notice Concerning the Status of Acquisition of Treasury Stock

July 2, 2026

Sysmex: Genetic Testing Using Sysmex’s Assay Kit Receives Insurance Coverage as the First of Its Kind in Japan for Assessing the Risk of Adverse Reactions to Anti-Amyloid β Antibody Drugs

July 1, 2026

Sysmex Selected as One of the World's Most Sustainable Companies 2026 by TIME

June 29, 2026

Notice of Resolutions at the 59th Ordinary General Meeting of Shareholders

June 25, 2026

Presentation(PDF format / 1.1MB)

May 14, 2026

Financial Statements(PDF format / 306KB)

May 14, 2026

Financial Data(PDF format / 741KB)

May 14, 2026

Notice Regarding Dividends from Surplus

May 14, 2026

Announcement of Executive Changes

May 14, 2026

Notice Concerning the Status of Acquisition of Treasury Stock

May 8, 2026

Sysmex: Included in S&P Dow Jones Indices’ Global ESG Index for the 10th Consecutive Year

May 7, 2026

Announcement Regarding Impairment Losses (Consolidated Financial Results), as well as Revision of Full-Year Financial Forecast for the Fiscal Year Ending March 31, 2026

April 28, 2026

Announcement of Organizational and Personnel Changes

March 5, 2026

Notice Regarding Share Repurchase and Cancellation of Treasury Stock

March 5, 2026

Sysmex: Ranked in the Top 1% in the Sustainability Yearbook 2026 by S&P Global

February 20, 2026

Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2026

February 12, 2026

Notice of Changes in Representative Directors

February 12, 2026

Financial Statements(PDF format / 292KB)

February 12, 2026

Announcement Regarding Revision of Full-Year Financial Forecast for the Fiscal Year Ending March 31, 2026

February 12, 2026

Presentation(PDF format / 5.5MB)

February 12, 2026

Financial Data(PDF format / 718KB)

February 12, 2026

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing

February 5, 2026

Launch of “CN™-9000 Automated Hemostasis Solution” for Large-Scale Laboratories in North America - Supporting the Optimization of Laboratory Workflow - (Sysmex America)

January 21, 2026

Sysmex Corporation Receives Health Canada License for the CN-3000™ & CN-6000™ Automated Blood Coagulation Analyzers

June 25, 2025

Sysmex America Receives FDA Clearance for Automated Blood Coagulation Analyzer CN-Series CN-6000™

June 25, 2025

Decks

The 5 newest of 23 decks. Every deck is listed under its year.